Commentary	Ref	Literature(PubmedID)	Inhibitor	value
	291	18341251	2-(p-nitrobenzyl)benzoxazole	0.0174
	291	18341251	5-chloro-2-(4-methylphenyl)benzoxazole	0.0223
	291	18341251	5-nitro-2-(4-nitrobenzyl)benzoxazole	0.09141
	291	18341251	etoposide	0.17
	291	18341251	5-amino-4-(p-methylbenzyl)benzoxazole	0.1867
	291	18341251	5-amino-4-(p-fluorophenyl)benzoxazole	0.4878
	291	18341251	5-amino-4-phenylbenzoxazole	0.58
	292	18341251	2-(p-nitrobenzyl)benzoxazole	0.0174
	292	18341251	5-chloro-2-(4-methylphenyl)benzoxazole	0.0223
	292	18341251	5-nitro-2-(4-nitrobenzyl)benzoxazole	0.09141
	292	18341251	etoposide	0.17
	292	18341251	5-amino-4-(p-methylbenzyl)benzoxazole	0.1867
	292	18341251	5-amino-4-(p-fluorophenyl)benzoxazole	0.4878
	292	18341251	5-amino-4-phenylbenzoxazole	0.58
	293	18341251	2-(p-nitrobenzyl)benzoxazole	0.0174
	293	18341251	5-chloro-2-(4-methylphenyl)benzoxazole	0.0223
	293	18341251	5-nitro-2-(4-nitrobenzyl)benzoxazole	0.09141
	293	18341251	etoposide	0.17
	293	18341251	5-amino-4-(p-methylbenzyl)benzoxazole	0.1867
	293	18341251	5-amino-4-(p-fluorophenyl)benzoxazole	0.4878
	293	18341251	5-amino-4-phenylbenzoxazole	0.58
	294	18341251	2-(p-nitrobenzyl)benzoxazole	0.0174
	294	18341251	5-chloro-2-(4-methylphenyl)benzoxazole	0.0223
	294	18341251	5-nitro-2-(4-nitrobenzyl)benzoxazole	0.09141
	294	18341251	etoposide	0.17
	294	18341251	5-amino-4-(p-methylbenzyl)benzoxazole	0.1867
	294	18341251	5-amino-4-(p-fluorophenyl)benzoxazole	0.4878
	294	18341251	5-amino-4-phenylbenzoxazole	0.58
	295	18341251	2-(p-nitrobenzyl)benzoxazole	0.0174
	295	18341251	5-chloro-2-(4-methylphenyl)benzoxazole	0.0223
	295	18341251	5-nitro-2-(4-nitrobenzyl)benzoxazole	0.09141
	295	18341251	etoposide	0.17
	295	18341251	5-amino-4-(p-methylbenzyl)benzoxazole	0.1867
	295	18341251	5-amino-4-(p-fluorophenyl)benzoxazole	0.4878
	295	18341251	5-amino-4-phenylbenzoxazole	0.58
	296	18341251	2-(p-nitrobenzyl)benzoxazole	0.0174
	296	18341251	5-chloro-2-(4-methylphenyl)benzoxazole	0.0223
	296	18341251	5-nitro-2-(4-nitrobenzyl)benzoxazole	0.09141
	296	18341251	etoposide	0.17
	296	18341251	5-amino-4-(p-methylbenzyl)benzoxazole	0.1867
	296	18341251	5-amino-4-(p-fluorophenyl)benzoxazole	0.4878
	296	18341251	5-amino-4-phenylbenzoxazole	0.58
	297	18341251	2-(p-nitrobenzyl)benzoxazole	0.0174
	297	18341251	5-chloro-2-(4-methylphenyl)benzoxazole	0.0223
	297	18341251	5-nitro-2-(4-nitrobenzyl)benzoxazole	0.09141
	297	18341251	etoposide	0.17
	297	18341251	5-amino-4-(p-methylbenzyl)benzoxazole	0.1867
	297	18341251	5-amino-4-(p-fluorophenyl)benzoxazole	0.4878
	297	18341251	5-amino-4-phenylbenzoxazole	0.58
in CHO-XRS6 cells	556	19047165	F14512	2.6E-7
in CHO-K1 cells	556	19047165	F14512	1.09E-5
in CHO cells	556	19047165	F14512	1.2E-4
in CHO-K1 cells	556	19047165	etoposide	1.94E-4
in CHO-XRS6 cells	556	19047165	etoposide	4.18E-4
in CHO-MG cells	556	19047165	F14512	0.0087
	556	18541453	(-)-epicatechin	0.0372
	556	18541453	(+)-catechin	0.046
	556	18541453	(-)-epigallocatechin	3.61
	556	18541453	(-)-epigallocatechin-3-gallate	3.78
in CHO-XRS6 cells	557	19047165	F14512	2.6E-7
in CHO-K1 cells	557	19047165	F14512	1.09E-5
in CHO cells	557	19047165	F14512	1.2E-4
in CHO-K1 cells	557	19047165	etoposide	1.94E-4
in CHO-XRS6 cells	557	19047165	etoposide	4.18E-4
in CHO-MG cells	557	19047165	F14512	0.0087
	557	18541453	(-)-epicatechin	0.0372
	557	18541453	(+)-catechin	0.046
	557	18541453	(-)-epigallocatechin	3.61
	557	18541453	(-)-epigallocatechin-3-gallate	3.78
in CHO-XRS6 cells	558	19047165	F14512	2.6E-7
in CHO-K1 cells	558	19047165	F14512	1.09E-5
in CHO cells	558	19047165	F14512	1.2E-4
in CHO-K1 cells	558	19047165	etoposide	1.94E-4
in CHO-XRS6 cells	558	19047165	etoposide	4.18E-4
in CHO-MG cells	558	19047165	F14512	0.0087
	558	18541453	(-)-epicatechin	0.0372
	558	18541453	(+)-catechin	0.046
	558	18541453	(-)-epigallocatechin	3.61
	558	18541453	(-)-epigallocatechin-3-gallate	3.78
in CHO-XRS6 cells	559	19047165	F14512	2.6E-7
in CHO-K1 cells	559	19047165	F14512	1.09E-5
in CHO cells	559	19047165	F14512	1.2E-4
in CHO-K1 cells	559	19047165	etoposide	1.94E-4
in CHO-XRS6 cells	559	19047165	etoposide	4.18E-4
in CHO-MG cells	559	19047165	F14512	0.0087
	559	18541453	(-)-epicatechin	0.0372
	559	18541453	(+)-catechin	0.046
	559	18541453	(-)-epigallocatechin	3.61
	559	18541453	(-)-epigallocatechin-3-gallate	3.78
in CHO-XRS6 cells	560	19047165	F14512	2.6E-7
in CHO-K1 cells	560	19047165	F14512	1.09E-5
in CHO cells	560	19047165	F14512	1.2E-4
in CHO-K1 cells	560	19047165	etoposide	1.94E-4
in CHO-XRS6 cells	560	19047165	etoposide	4.18E-4
in CHO-MG cells	560	19047165	F14512	0.0087
	560	18541453	(-)-epicatechin	0.0372
	560	18541453	(+)-catechin	0.046
	560	18541453	(-)-epigallocatechin	3.61
	560	18541453	(-)-epigallocatechin-3-gallate	3.78
in CHO-XRS6 cells	561	19047165	F14512	2.6E-7
in CHO-K1 cells	561	19047165	F14512	1.09E-5
in CHO cells	561	19047165	F14512	1.2E-4
in CHO-K1 cells	561	19047165	etoposide	1.94E-4
in CHO-XRS6 cells	561	19047165	etoposide	4.18E-4
in CHO-MG cells	561	19047165	F14512	0.0087
	561	18541453	(-)-epicatechin	0.0372
	561	18541453	(+)-catechin	0.046
	561	18541453	(-)-epigallocatechin	3.61
	561	18541453	(-)-epigallocatechin-3-gallate	3.78
in CHO-XRS6 cells	562	19047165	F14512	2.6E-7
in CHO-K1 cells	562	19047165	F14512	1.09E-5
in CHO cells	562	19047165	F14512	1.2E-4
in CHO-K1 cells	562	19047165	etoposide	1.94E-4
in CHO-XRS6 cells	562	19047165	etoposide	4.18E-4
in CHO-MG cells	562	19047165	F14512	0.0087
	562	18541453	(-)-epicatechin	0.0372
	562	18541453	(+)-catechin	0.046
	562	18541453	(-)-epigallocatechin	3.61
	562	18541453	(-)-epigallocatechin-3-gallate	3.78
inhibitor IC50 values in vivo in different cancer cell lines, overview	984	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	984	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	984	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	984	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	984	24775914	more	-999.0
pH 8.0, 37°C	984	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	984	16536579	myricetin	3.9E-5
at 37°C	984	19128485	ICRF-193	2.0E-4
pH 8.0	984	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	suramin	3.0E-4
pH 8.0	984	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	984	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	984	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	984	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	984	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	984	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	984	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	984	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	984	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	984	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	984	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	984	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	984	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	984	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	984	17391647	aclacinomycin A	0.002
	984	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	984	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	984	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	984	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	984	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	quercetin	0.0036
pH 8.0	984	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	984	16536579	procyanidin B2	0.0045
pH 8.0	984	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	984	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	984	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	984	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	984	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	984	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	suramin	0.021
pH 8.0, 37°C	984	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	984	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	984	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	984	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	984	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	984	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	984	16536579	resveratrol	0.0657
pH 8.0, 37°C	984	17466980	coralyne	0.074
	984	17194596	etoposide	0.0784
IC50: 0.08 mM	984	12745084	betulinic acid	0.08
IC50: 0.081 mM	984	12745084	oleanolic acid	0.081
IC50: 0.083 mM	984	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	984	17466980	quercetin	0.0889
IC50: 0.089 mM	984	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	984	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	984	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	984	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	984	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	984	16819200	hemsleyanol	1.0
pH 8.0, 37°C	984	17466980	Pentamidine	1.426
pH 8.0, 37°C	984	17466980	enoxacin	1.485
pH 8.0, 37°C	984	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	984	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	984	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	984	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	984	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	984	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	984	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	984	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	984	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	984	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	984	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	984	18593177	VFDGEL	7.9
pH 7.9, 30°C	984	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	985	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	985	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	985	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	985	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	985	24775914	more	-999.0
pH 8.0, 37°C	985	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	985	16536579	myricetin	3.9E-5
at 37°C	985	19128485	ICRF-193	2.0E-4
pH 8.0	985	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	suramin	3.0E-4
pH 8.0	985	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	985	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	985	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	985	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	985	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	985	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	985	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	985	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	985	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	985	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	985	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	985	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	985	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	985	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	985	17391647	aclacinomycin A	0.002
	985	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	985	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	985	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	985	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	985	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	quercetin	0.0036
pH 8.0	985	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	985	16536579	procyanidin B2	0.0045
pH 8.0	985	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	985	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	985	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	985	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	985	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	985	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	suramin	0.021
pH 8.0, 37°C	985	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	985	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	985	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	985	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	985	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	985	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	985	16536579	resveratrol	0.0657
pH 8.0, 37°C	985	17466980	coralyne	0.074
	985	17194596	etoposide	0.0784
IC50: 0.08 mM	985	12745084	betulinic acid	0.08
IC50: 0.081 mM	985	12745084	oleanolic acid	0.081
IC50: 0.083 mM	985	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	985	17466980	quercetin	0.0889
IC50: 0.089 mM	985	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	985	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	985	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	985	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	985	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	985	16819200	hemsleyanol	1.0
pH 8.0, 37°C	985	17466980	Pentamidine	1.426
pH 8.0, 37°C	985	17466980	enoxacin	1.485
pH 8.0, 37°C	985	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	985	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	985	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	985	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	985	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	985	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	985	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	985	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	985	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	985	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	985	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	985	18593177	VFDGEL	7.9
pH 7.9, 30°C	985	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	986	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	986	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	986	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	986	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	986	24775914	more	-999.0
pH 8.0, 37°C	986	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	986	16536579	myricetin	3.9E-5
at 37°C	986	19128485	ICRF-193	2.0E-4
pH 8.0	986	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	suramin	3.0E-4
pH 8.0	986	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	986	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	986	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	986	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	986	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	986	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	986	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	986	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	986	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	986	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	986	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	986	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	986	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	986	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	986	17391647	aclacinomycin A	0.002
	986	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	986	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	986	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	986	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	986	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	quercetin	0.0036
pH 8.0	986	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	986	16536579	procyanidin B2	0.0045
pH 8.0	986	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	986	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	986	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	986	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	986	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	986	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	suramin	0.021
pH 8.0, 37°C	986	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	986	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	986	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	986	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	986	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	986	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	986	16536579	resveratrol	0.0657
pH 8.0, 37°C	986	17466980	coralyne	0.074
	986	17194596	etoposide	0.0784
IC50: 0.08 mM	986	12745084	betulinic acid	0.08
IC50: 0.081 mM	986	12745084	oleanolic acid	0.081
IC50: 0.083 mM	986	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	986	17466980	quercetin	0.0889
IC50: 0.089 mM	986	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	986	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	986	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	986	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	986	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	986	16819200	hemsleyanol	1.0
pH 8.0, 37°C	986	17466980	Pentamidine	1.426
pH 8.0, 37°C	986	17466980	enoxacin	1.485
pH 8.0, 37°C	986	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	986	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	986	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	986	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	986	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	986	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	986	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	986	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	986	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	986	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	986	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	986	18593177	VFDGEL	7.9
pH 7.9, 30°C	986	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	987	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	987	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	987	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	987	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	987	24775914	more	-999.0
pH 8.0, 37°C	987	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	987	16536579	myricetin	3.9E-5
at 37°C	987	19128485	ICRF-193	2.0E-4
pH 8.0	987	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	suramin	3.0E-4
pH 8.0	987	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	987	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	987	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	987	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	987	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	987	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	987	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	987	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	987	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	987	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	987	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	987	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	987	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	987	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	987	17391647	aclacinomycin A	0.002
	987	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	987	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	987	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	987	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	987	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	quercetin	0.0036
pH 8.0	987	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	987	16536579	procyanidin B2	0.0045
pH 8.0	987	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	987	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	987	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	987	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	987	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	987	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	suramin	0.021
pH 8.0, 37°C	987	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	987	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	987	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	987	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	987	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	987	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	987	16536579	resveratrol	0.0657
pH 8.0, 37°C	987	17466980	coralyne	0.074
	987	17194596	etoposide	0.0784
IC50: 0.08 mM	987	12745084	betulinic acid	0.08
IC50: 0.081 mM	987	12745084	oleanolic acid	0.081
IC50: 0.083 mM	987	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	987	17466980	quercetin	0.0889
IC50: 0.089 mM	987	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	987	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	987	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	987	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	987	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	987	16819200	hemsleyanol	1.0
pH 8.0, 37°C	987	17466980	Pentamidine	1.426
pH 8.0, 37°C	987	17466980	enoxacin	1.485
pH 8.0, 37°C	987	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	987	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	987	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	987	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	987	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	987	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	987	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	987	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	987	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	987	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	987	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	987	18593177	VFDGEL	7.9
pH 7.9, 30°C	987	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	988	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	988	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	988	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	988	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	988	24775914	more	-999.0
pH 8.0, 37°C	988	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	988	16536579	myricetin	3.9E-5
at 37°C	988	19128485	ICRF-193	2.0E-4
pH 8.0	988	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	suramin	3.0E-4
pH 8.0	988	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	988	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	988	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	988	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	988	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	988	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	988	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	988	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	988	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	988	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	988	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	988	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	988	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	988	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	988	17391647	aclacinomycin A	0.002
	988	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	988	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	988	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	988	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	988	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	quercetin	0.0036
pH 8.0	988	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	988	16536579	procyanidin B2	0.0045
pH 8.0	988	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	988	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	988	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	988	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	988	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	988	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	suramin	0.021
pH 8.0, 37°C	988	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	988	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	988	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	988	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	988	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	988	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	988	16536579	resveratrol	0.0657
pH 8.0, 37°C	988	17466980	coralyne	0.074
	988	17194596	etoposide	0.0784
IC50: 0.08 mM	988	12745084	betulinic acid	0.08
IC50: 0.081 mM	988	12745084	oleanolic acid	0.081
IC50: 0.083 mM	988	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	988	17466980	quercetin	0.0889
IC50: 0.089 mM	988	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	988	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	988	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	988	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	988	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	988	16819200	hemsleyanol	1.0
pH 8.0, 37°C	988	17466980	Pentamidine	1.426
pH 8.0, 37°C	988	17466980	enoxacin	1.485
pH 8.0, 37°C	988	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	988	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	988	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	988	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	988	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	988	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	988	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	988	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	988	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	988	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	988	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	988	18593177	VFDGEL	7.9
pH 7.9, 30°C	988	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	989	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	989	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	989	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	989	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	989	24775914	more	-999.0
pH 8.0, 37°C	989	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	989	16536579	myricetin	3.9E-5
at 37°C	989	19128485	ICRF-193	2.0E-4
pH 8.0	989	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	suramin	3.0E-4
pH 8.0	989	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	989	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	989	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	989	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	989	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	989	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	989	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	989	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	989	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	989	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	989	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	989	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	989	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	989	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	989	17391647	aclacinomycin A	0.002
	989	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	989	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	989	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	989	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	989	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	quercetin	0.0036
pH 8.0	989	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	989	16536579	procyanidin B2	0.0045
pH 8.0	989	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	989	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	989	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	989	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	989	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	989	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	suramin	0.021
pH 8.0, 37°C	989	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	989	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	989	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	989	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	989	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	989	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	989	16536579	resveratrol	0.0657
pH 8.0, 37°C	989	17466980	coralyne	0.074
	989	17194596	etoposide	0.0784
IC50: 0.08 mM	989	12745084	betulinic acid	0.08
IC50: 0.081 mM	989	12745084	oleanolic acid	0.081
IC50: 0.083 mM	989	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	989	17466980	quercetin	0.0889
IC50: 0.089 mM	989	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	989	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	989	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	989	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	989	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	989	16819200	hemsleyanol	1.0
pH 8.0, 37°C	989	17466980	Pentamidine	1.426
pH 8.0, 37°C	989	17466980	enoxacin	1.485
pH 8.0, 37°C	989	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	989	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	989	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	989	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	989	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	989	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	989	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	989	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	989	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	989	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	989	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	989	18593177	VFDGEL	7.9
pH 7.9, 30°C	989	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	990	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	990	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	990	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	990	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	990	24775914	more	-999.0
pH 8.0, 37°C	990	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	990	16536579	myricetin	3.9E-5
at 37°C	990	19128485	ICRF-193	2.0E-4
pH 8.0	990	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	suramin	3.0E-4
pH 8.0	990	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	990	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	990	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	990	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	990	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	990	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	990	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	990	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	990	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	990	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	990	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	990	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	990	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	990	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	990	17391647	aclacinomycin A	0.002
	990	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	990	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	990	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	990	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	990	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	quercetin	0.0036
pH 8.0	990	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	990	16536579	procyanidin B2	0.0045
pH 8.0	990	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	990	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	990	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	990	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	990	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	990	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	suramin	0.021
pH 8.0, 37°C	990	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	990	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	990	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	990	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	990	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	990	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	990	16536579	resveratrol	0.0657
pH 8.0, 37°C	990	17466980	coralyne	0.074
	990	17194596	etoposide	0.0784
IC50: 0.08 mM	990	12745084	betulinic acid	0.08
IC50: 0.081 mM	990	12745084	oleanolic acid	0.081
IC50: 0.083 mM	990	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	990	17466980	quercetin	0.0889
IC50: 0.089 mM	990	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	990	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	990	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	990	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	990	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	990	16819200	hemsleyanol	1.0
pH 8.0, 37°C	990	17466980	Pentamidine	1.426
pH 8.0, 37°C	990	17466980	enoxacin	1.485
pH 8.0, 37°C	990	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	990	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	990	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	990	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	990	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	990	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	990	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	990	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	990	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	990	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	990	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	990	18593177	VFDGEL	7.9
pH 7.9, 30°C	990	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	991	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	991	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	991	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	991	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	991	24775914	more	-999.0
pH 8.0, 37°C	991	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	991	16536579	myricetin	3.9E-5
at 37°C	991	19128485	ICRF-193	2.0E-4
pH 8.0	991	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	suramin	3.0E-4
pH 8.0	991	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	991	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	991	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	991	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	991	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	991	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	991	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	991	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	991	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	991	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	991	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	991	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	991	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	991	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	991	17391647	aclacinomycin A	0.002
	991	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	991	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	991	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	991	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	991	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	quercetin	0.0036
pH 8.0	991	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	991	16536579	procyanidin B2	0.0045
pH 8.0	991	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	991	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	991	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	991	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	991	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	991	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	suramin	0.021
pH 8.0, 37°C	991	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	991	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	991	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	991	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	991	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	991	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	991	16536579	resveratrol	0.0657
pH 8.0, 37°C	991	17466980	coralyne	0.074
	991	17194596	etoposide	0.0784
IC50: 0.08 mM	991	12745084	betulinic acid	0.08
IC50: 0.081 mM	991	12745084	oleanolic acid	0.081
IC50: 0.083 mM	991	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	991	17466980	quercetin	0.0889
IC50: 0.089 mM	991	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	991	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	991	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	991	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	991	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	991	16819200	hemsleyanol	1.0
pH 8.0, 37°C	991	17466980	Pentamidine	1.426
pH 8.0, 37°C	991	17466980	enoxacin	1.485
pH 8.0, 37°C	991	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	991	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	991	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	991	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	991	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	991	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	991	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	991	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	991	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	991	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	991	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	991	18593177	VFDGEL	7.9
pH 7.9, 30°C	991	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	992	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	992	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	992	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	992	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	992	24775914	more	-999.0
pH 8.0, 37°C	992	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	992	16536579	myricetin	3.9E-5
at 37°C	992	19128485	ICRF-193	2.0E-4
pH 8.0	992	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	suramin	3.0E-4
pH 8.0	992	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	992	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	992	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	992	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	992	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	992	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	992	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	992	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	992	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	992	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	992	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	992	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	992	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	992	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	992	17391647	aclacinomycin A	0.002
	992	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	992	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	992	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	992	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	992	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	quercetin	0.0036
pH 8.0	992	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	992	16536579	procyanidin B2	0.0045
pH 8.0	992	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	992	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	992	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	992	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	992	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	992	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	suramin	0.021
pH 8.0, 37°C	992	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	992	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	992	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	992	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	992	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	992	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	992	16536579	resveratrol	0.0657
pH 8.0, 37°C	992	17466980	coralyne	0.074
	992	17194596	etoposide	0.0784
IC50: 0.08 mM	992	12745084	betulinic acid	0.08
IC50: 0.081 mM	992	12745084	oleanolic acid	0.081
IC50: 0.083 mM	992	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	992	17466980	quercetin	0.0889
IC50: 0.089 mM	992	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	992	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	992	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	992	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	992	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	992	16819200	hemsleyanol	1.0
pH 8.0, 37°C	992	17466980	Pentamidine	1.426
pH 8.0, 37°C	992	17466980	enoxacin	1.485
pH 8.0, 37°C	992	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	992	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	992	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	992	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	992	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	992	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	992	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	992	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	992	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	992	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	992	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	992	18593177	VFDGEL	7.9
pH 7.9, 30°C	992	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	993	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	993	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	993	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	993	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	993	24775914	more	-999.0
pH 8.0, 37°C	993	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	993	16536579	myricetin	3.9E-5
at 37°C	993	19128485	ICRF-193	2.0E-4
pH 8.0	993	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	suramin	3.0E-4
pH 8.0	993	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	993	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	993	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	993	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	993	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	993	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	993	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	993	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	993	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	993	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	993	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	993	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	993	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	993	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	993	17391647	aclacinomycin A	0.002
	993	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	993	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	993	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	993	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	993	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	quercetin	0.0036
pH 8.0	993	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	993	16536579	procyanidin B2	0.0045
pH 8.0	993	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	993	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	993	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	993	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	993	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	993	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	suramin	0.021
pH 8.0, 37°C	993	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	993	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	993	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	993	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	993	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	993	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	993	16536579	resveratrol	0.0657
pH 8.0, 37°C	993	17466980	coralyne	0.074
	993	17194596	etoposide	0.0784
IC50: 0.08 mM	993	12745084	betulinic acid	0.08
IC50: 0.081 mM	993	12745084	oleanolic acid	0.081
IC50: 0.083 mM	993	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	993	17466980	quercetin	0.0889
IC50: 0.089 mM	993	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	993	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	993	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	993	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	993	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	993	16819200	hemsleyanol	1.0
pH 8.0, 37°C	993	17466980	Pentamidine	1.426
pH 8.0, 37°C	993	17466980	enoxacin	1.485
pH 8.0, 37°C	993	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	993	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	993	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	993	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	993	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	993	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	993	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	993	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	993	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	993	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	993	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	993	18593177	VFDGEL	7.9
pH 7.9, 30°C	993	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	994	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	994	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	994	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	994	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	994	24775914	more	-999.0
pH 8.0, 37°C	994	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	994	16536579	myricetin	3.9E-5
at 37°C	994	19128485	ICRF-193	2.0E-4
pH 8.0	994	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	suramin	3.0E-4
pH 8.0	994	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	994	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	994	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	994	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	994	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	994	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	994	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	994	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	994	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	994	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	994	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	994	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	994	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	994	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	994	17391647	aclacinomycin A	0.002
	994	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	994	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	994	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	994	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	994	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	quercetin	0.0036
pH 8.0	994	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	994	16536579	procyanidin B2	0.0045
pH 8.0	994	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	994	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	994	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	994	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	994	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	994	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	suramin	0.021
pH 8.0, 37°C	994	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	994	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	994	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	994	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	994	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	994	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	994	16536579	resveratrol	0.0657
pH 8.0, 37°C	994	17466980	coralyne	0.074
	994	17194596	etoposide	0.0784
IC50: 0.08 mM	994	12745084	betulinic acid	0.08
IC50: 0.081 mM	994	12745084	oleanolic acid	0.081
IC50: 0.083 mM	994	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	994	17466980	quercetin	0.0889
IC50: 0.089 mM	994	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	994	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	994	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	994	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	994	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	994	16819200	hemsleyanol	1.0
pH 8.0, 37°C	994	17466980	Pentamidine	1.426
pH 8.0, 37°C	994	17466980	enoxacin	1.485
pH 8.0, 37°C	994	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	994	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	994	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	994	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	994	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	994	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	994	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	994	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	994	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	994	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	994	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	994	18593177	VFDGEL	7.9
pH 7.9, 30°C	994	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	995	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	995	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	995	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	995	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	995	24775914	more	-999.0
pH 8.0, 37°C	995	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	995	16536579	myricetin	3.9E-5
at 37°C	995	19128485	ICRF-193	2.0E-4
pH 8.0	995	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	suramin	3.0E-4
pH 8.0	995	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	995	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	995	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	995	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	995	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	995	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	995	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	995	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	995	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	995	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	995	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	995	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	995	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	995	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	995	17391647	aclacinomycin A	0.002
	995	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	995	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	995	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	995	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	995	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	quercetin	0.0036
pH 8.0	995	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	995	16536579	procyanidin B2	0.0045
pH 8.0	995	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	995	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	995	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	995	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	995	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	995	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	suramin	0.021
pH 8.0, 37°C	995	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	995	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	995	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	995	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	995	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	995	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	995	16536579	resveratrol	0.0657
pH 8.0, 37°C	995	17466980	coralyne	0.074
	995	17194596	etoposide	0.0784
IC50: 0.08 mM	995	12745084	betulinic acid	0.08
IC50: 0.081 mM	995	12745084	oleanolic acid	0.081
IC50: 0.083 mM	995	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	995	17466980	quercetin	0.0889
IC50: 0.089 mM	995	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	995	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	995	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	995	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	995	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	995	16819200	hemsleyanol	1.0
pH 8.0, 37°C	995	17466980	Pentamidine	1.426
pH 8.0, 37°C	995	17466980	enoxacin	1.485
pH 8.0, 37°C	995	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	995	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	995	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	995	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	995	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	995	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	995	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	995	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	995	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	995	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	995	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	995	18593177	VFDGEL	7.9
pH 7.9, 30°C	995	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	996	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	996	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	996	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	996	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	996	24775914	more	-999.0
pH 8.0, 37°C	996	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	996	16536579	myricetin	3.9E-5
at 37°C	996	19128485	ICRF-193	2.0E-4
pH 8.0	996	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	suramin	3.0E-4
pH 8.0	996	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	996	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	996	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	996	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	996	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	996	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	996	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	996	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	996	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	996	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	996	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	996	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	996	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	996	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	996	17391647	aclacinomycin A	0.002
	996	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	996	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	996	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	996	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	996	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	quercetin	0.0036
pH 8.0	996	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	996	16536579	procyanidin B2	0.0045
pH 8.0	996	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	996	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	996	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	996	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	996	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	996	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	suramin	0.021
pH 8.0, 37°C	996	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	996	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	996	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	996	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	996	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	996	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	996	16536579	resveratrol	0.0657
pH 8.0, 37°C	996	17466980	coralyne	0.074
	996	17194596	etoposide	0.0784
IC50: 0.08 mM	996	12745084	betulinic acid	0.08
IC50: 0.081 mM	996	12745084	oleanolic acid	0.081
IC50: 0.083 mM	996	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	996	17466980	quercetin	0.0889
IC50: 0.089 mM	996	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	996	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	996	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	996	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	996	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	996	16819200	hemsleyanol	1.0
pH 8.0, 37°C	996	17466980	Pentamidine	1.426
pH 8.0, 37°C	996	17466980	enoxacin	1.485
pH 8.0, 37°C	996	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	996	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	996	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	996	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	996	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	996	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	996	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	996	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	996	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	996	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	996	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	996	18593177	VFDGEL	7.9
pH 7.9, 30°C	996	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	997	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	997	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	997	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	997	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	997	24775914	more	-999.0
pH 8.0, 37°C	997	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	997	16536579	myricetin	3.9E-5
at 37°C	997	19128485	ICRF-193	2.0E-4
pH 8.0	997	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	suramin	3.0E-4
pH 8.0	997	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	997	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	997	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	997	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	997	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	997	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	997	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	997	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	997	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	997	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	997	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	997	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	997	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	997	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	997	17391647	aclacinomycin A	0.002
	997	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	997	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	997	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	997	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	997	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	quercetin	0.0036
pH 8.0	997	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	997	16536579	procyanidin B2	0.0045
pH 8.0	997	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	997	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	997	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	997	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	997	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	997	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	suramin	0.021
pH 8.0, 37°C	997	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	997	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	997	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	997	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	997	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	997	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	997	16536579	resveratrol	0.0657
pH 8.0, 37°C	997	17466980	coralyne	0.074
	997	17194596	etoposide	0.0784
IC50: 0.08 mM	997	12745084	betulinic acid	0.08
IC50: 0.081 mM	997	12745084	oleanolic acid	0.081
IC50: 0.083 mM	997	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	997	17466980	quercetin	0.0889
IC50: 0.089 mM	997	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	997	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	997	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	997	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	997	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	997	16819200	hemsleyanol	1.0
pH 8.0, 37°C	997	17466980	Pentamidine	1.426
pH 8.0, 37°C	997	17466980	enoxacin	1.485
pH 8.0, 37°C	997	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	997	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	997	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	997	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	997	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	997	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	997	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	997	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	997	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	997	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	997	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	997	18593177	VFDGEL	7.9
pH 7.9, 30°C	997	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	998	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	998	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	998	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	998	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	998	24775914	more	-999.0
pH 8.0, 37°C	998	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	998	16536579	myricetin	3.9E-5
at 37°C	998	19128485	ICRF-193	2.0E-4
pH 8.0	998	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	suramin	3.0E-4
pH 8.0	998	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	998	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	998	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	998	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	998	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	998	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	998	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	998	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	998	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	998	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	998	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	998	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	998	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	998	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	998	17391647	aclacinomycin A	0.002
	998	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	998	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	998	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	998	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	998	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	quercetin	0.0036
pH 8.0	998	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	998	16536579	procyanidin B2	0.0045
pH 8.0	998	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	998	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	998	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	998	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	998	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	998	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	suramin	0.021
pH 8.0, 37°C	998	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	998	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	998	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	998	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	998	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	998	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	998	16536579	resveratrol	0.0657
pH 8.0, 37°C	998	17466980	coralyne	0.074
	998	17194596	etoposide	0.0784
IC50: 0.08 mM	998	12745084	betulinic acid	0.08
IC50: 0.081 mM	998	12745084	oleanolic acid	0.081
IC50: 0.083 mM	998	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	998	17466980	quercetin	0.0889
IC50: 0.089 mM	998	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	998	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	998	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	998	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	998	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	998	16819200	hemsleyanol	1.0
pH 8.0, 37°C	998	17466980	Pentamidine	1.426
pH 8.0, 37°C	998	17466980	enoxacin	1.485
pH 8.0, 37°C	998	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	998	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	998	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	998	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	998	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	998	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	998	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	998	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	998	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	998	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	998	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	998	18593177	VFDGEL	7.9
pH 7.9, 30°C	998	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	999	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	999	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	999	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	999	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	999	24775914	more	-999.0
pH 8.0, 37°C	999	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	999	16536579	myricetin	3.9E-5
at 37°C	999	19128485	ICRF-193	2.0E-4
pH 8.0	999	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	suramin	3.0E-4
pH 8.0	999	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	999	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	999	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	999	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	999	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	999	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	999	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	999	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	999	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	999	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	999	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	999	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	999	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	999	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	999	17391647	aclacinomycin A	0.002
	999	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	999	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	999	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	999	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	999	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	quercetin	0.0036
pH 8.0	999	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	999	16536579	procyanidin B2	0.0045
pH 8.0	999	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	999	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	999	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	999	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	999	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	999	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	suramin	0.021
pH 8.0, 37°C	999	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	999	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	999	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	999	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	999	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	999	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	999	16536579	resveratrol	0.0657
pH 8.0, 37°C	999	17466980	coralyne	0.074
	999	17194596	etoposide	0.0784
IC50: 0.08 mM	999	12745084	betulinic acid	0.08
IC50: 0.081 mM	999	12745084	oleanolic acid	0.081
IC50: 0.083 mM	999	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	999	17466980	quercetin	0.0889
IC50: 0.089 mM	999	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	999	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	999	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	999	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	999	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	999	16819200	hemsleyanol	1.0
pH 8.0, 37°C	999	17466980	Pentamidine	1.426
pH 8.0, 37°C	999	17466980	enoxacin	1.485
pH 8.0, 37°C	999	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	999	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	999	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	999	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	999	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	999	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	999	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	999	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	999	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	999	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	999	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	999	18593177	VFDGEL	7.9
pH 7.9, 30°C	999	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1000	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1000	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1000	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1000	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1000	24775914	more	-999.0
pH 8.0, 37°C	1000	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1000	16536579	myricetin	3.9E-5
at 37°C	1000	19128485	ICRF-193	2.0E-4
pH 8.0	1000	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	suramin	3.0E-4
pH 8.0	1000	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1000	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1000	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1000	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1000	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1000	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1000	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1000	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1000	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1000	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1000	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1000	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1000	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1000	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1000	17391647	aclacinomycin A	0.002
	1000	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1000	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1000	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1000	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1000	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	quercetin	0.0036
pH 8.0	1000	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1000	16536579	procyanidin B2	0.0045
pH 8.0	1000	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1000	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1000	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1000	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1000	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1000	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	suramin	0.021
pH 8.0, 37°C	1000	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1000	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1000	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1000	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1000	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1000	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1000	16536579	resveratrol	0.0657
pH 8.0, 37°C	1000	17466980	coralyne	0.074
	1000	17194596	etoposide	0.0784
IC50: 0.08 mM	1000	12745084	betulinic acid	0.08
IC50: 0.081 mM	1000	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1000	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1000	17466980	quercetin	0.0889
IC50: 0.089 mM	1000	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1000	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1000	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1000	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1000	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1000	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1000	17466980	Pentamidine	1.426
pH 8.0, 37°C	1000	17466980	enoxacin	1.485
pH 8.0, 37°C	1000	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1000	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1000	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1000	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1000	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1000	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1000	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1000	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1000	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1000	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1000	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1000	18593177	VFDGEL	7.9
pH 7.9, 30°C	1000	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1001	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1001	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1001	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1001	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1001	24775914	more	-999.0
pH 8.0, 37°C	1001	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1001	16536579	myricetin	3.9E-5
at 37°C	1001	19128485	ICRF-193	2.0E-4
pH 8.0	1001	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	suramin	3.0E-4
pH 8.0	1001	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1001	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1001	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1001	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1001	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1001	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1001	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1001	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1001	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1001	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1001	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1001	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1001	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1001	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1001	17391647	aclacinomycin A	0.002
	1001	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1001	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1001	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1001	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1001	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	quercetin	0.0036
pH 8.0	1001	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1001	16536579	procyanidin B2	0.0045
pH 8.0	1001	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1001	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1001	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1001	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1001	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1001	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	suramin	0.021
pH 8.0, 37°C	1001	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1001	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1001	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1001	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1001	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1001	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1001	16536579	resveratrol	0.0657
pH 8.0, 37°C	1001	17466980	coralyne	0.074
	1001	17194596	etoposide	0.0784
IC50: 0.08 mM	1001	12745084	betulinic acid	0.08
IC50: 0.081 mM	1001	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1001	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1001	17466980	quercetin	0.0889
IC50: 0.089 mM	1001	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1001	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1001	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1001	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1001	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1001	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1001	17466980	Pentamidine	1.426
pH 8.0, 37°C	1001	17466980	enoxacin	1.485
pH 8.0, 37°C	1001	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1001	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1001	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1001	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1001	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1001	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1001	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1001	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1001	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1001	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1001	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1001	18593177	VFDGEL	7.9
pH 7.9, 30°C	1001	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1002	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1002	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1002	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1002	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1002	24775914	more	-999.0
pH 8.0, 37°C	1002	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1002	16536579	myricetin	3.9E-5
at 37°C	1002	19128485	ICRF-193	2.0E-4
pH 8.0	1002	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	suramin	3.0E-4
pH 8.0	1002	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1002	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1002	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1002	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1002	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1002	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1002	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1002	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1002	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1002	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1002	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1002	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1002	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1002	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1002	17391647	aclacinomycin A	0.002
	1002	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1002	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1002	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1002	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1002	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	quercetin	0.0036
pH 8.0	1002	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1002	16536579	procyanidin B2	0.0045
pH 8.0	1002	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1002	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1002	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1002	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1002	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1002	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	suramin	0.021
pH 8.0, 37°C	1002	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1002	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1002	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1002	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1002	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1002	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1002	16536579	resveratrol	0.0657
pH 8.0, 37°C	1002	17466980	coralyne	0.074
	1002	17194596	etoposide	0.0784
IC50: 0.08 mM	1002	12745084	betulinic acid	0.08
IC50: 0.081 mM	1002	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1002	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1002	17466980	quercetin	0.0889
IC50: 0.089 mM	1002	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1002	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1002	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1002	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1002	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1002	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1002	17466980	Pentamidine	1.426
pH 8.0, 37°C	1002	17466980	enoxacin	1.485
pH 8.0, 37°C	1002	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1002	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1002	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1002	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1002	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1002	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1002	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1002	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1002	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1002	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1002	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1002	18593177	VFDGEL	7.9
pH 7.9, 30°C	1002	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1003	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1003	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1003	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1003	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1003	24775914	more	-999.0
pH 8.0, 37°C	1003	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1003	16536579	myricetin	3.9E-5
at 37°C	1003	19128485	ICRF-193	2.0E-4
pH 8.0	1003	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	suramin	3.0E-4
pH 8.0	1003	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1003	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1003	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1003	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1003	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1003	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1003	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1003	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1003	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1003	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1003	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1003	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1003	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1003	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1003	17391647	aclacinomycin A	0.002
	1003	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1003	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1003	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1003	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1003	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	quercetin	0.0036
pH 8.0	1003	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1003	16536579	procyanidin B2	0.0045
pH 8.0	1003	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1003	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1003	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1003	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1003	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1003	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	suramin	0.021
pH 8.0, 37°C	1003	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1003	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1003	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1003	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1003	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1003	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1003	16536579	resveratrol	0.0657
pH 8.0, 37°C	1003	17466980	coralyne	0.074
	1003	17194596	etoposide	0.0784
IC50: 0.08 mM	1003	12745084	betulinic acid	0.08
IC50: 0.081 mM	1003	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1003	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1003	17466980	quercetin	0.0889
IC50: 0.089 mM	1003	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1003	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1003	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1003	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1003	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1003	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1003	17466980	Pentamidine	1.426
pH 8.0, 37°C	1003	17466980	enoxacin	1.485
pH 8.0, 37°C	1003	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1003	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1003	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1003	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1003	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1003	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1003	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1003	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1003	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1003	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1003	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1003	18593177	VFDGEL	7.9
pH 7.9, 30°C	1003	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1004	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1004	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1004	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1004	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1004	24775914	more	-999.0
pH 8.0, 37°C	1004	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1004	16536579	myricetin	3.9E-5
at 37°C	1004	19128485	ICRF-193	2.0E-4
pH 8.0	1004	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	suramin	3.0E-4
pH 8.0	1004	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1004	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1004	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1004	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1004	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1004	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1004	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1004	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1004	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1004	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1004	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1004	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1004	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1004	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1004	17391647	aclacinomycin A	0.002
	1004	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1004	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1004	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1004	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1004	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	quercetin	0.0036
pH 8.0	1004	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1004	16536579	procyanidin B2	0.0045
pH 8.0	1004	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1004	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1004	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1004	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1004	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1004	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	suramin	0.021
pH 8.0, 37°C	1004	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1004	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1004	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1004	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1004	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1004	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1004	16536579	resveratrol	0.0657
pH 8.0, 37°C	1004	17466980	coralyne	0.074
	1004	17194596	etoposide	0.0784
IC50: 0.08 mM	1004	12745084	betulinic acid	0.08
IC50: 0.081 mM	1004	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1004	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1004	17466980	quercetin	0.0889
IC50: 0.089 mM	1004	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1004	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1004	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1004	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1004	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1004	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1004	17466980	Pentamidine	1.426
pH 8.0, 37°C	1004	17466980	enoxacin	1.485
pH 8.0, 37°C	1004	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1004	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1004	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1004	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1004	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1004	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1004	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1004	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1004	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1004	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1004	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1004	18593177	VFDGEL	7.9
pH 7.9, 30°C	1004	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1005	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1005	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1005	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1005	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1005	24775914	more	-999.0
pH 8.0, 37°C	1005	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1005	16536579	myricetin	3.9E-5
at 37°C	1005	19128485	ICRF-193	2.0E-4
pH 8.0	1005	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	suramin	3.0E-4
pH 8.0	1005	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1005	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1005	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1005	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1005	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1005	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1005	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1005	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1005	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1005	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1005	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1005	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1005	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1005	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1005	17391647	aclacinomycin A	0.002
	1005	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1005	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1005	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1005	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1005	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	quercetin	0.0036
pH 8.0	1005	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1005	16536579	procyanidin B2	0.0045
pH 8.0	1005	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1005	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1005	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1005	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1005	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1005	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	suramin	0.021
pH 8.0, 37°C	1005	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1005	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1005	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1005	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1005	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1005	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1005	16536579	resveratrol	0.0657
pH 8.0, 37°C	1005	17466980	coralyne	0.074
	1005	17194596	etoposide	0.0784
IC50: 0.08 mM	1005	12745084	betulinic acid	0.08
IC50: 0.081 mM	1005	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1005	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1005	17466980	quercetin	0.0889
IC50: 0.089 mM	1005	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1005	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1005	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1005	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1005	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1005	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1005	17466980	Pentamidine	1.426
pH 8.0, 37°C	1005	17466980	enoxacin	1.485
pH 8.0, 37°C	1005	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1005	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1005	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1005	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1005	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1005	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1005	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1005	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1005	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1005	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1005	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1005	18593177	VFDGEL	7.9
pH 7.9, 30°C	1005	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1006	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1006	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1006	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1006	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1006	24775914	more	-999.0
pH 8.0, 37°C	1006	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1006	16536579	myricetin	3.9E-5
at 37°C	1006	19128485	ICRF-193	2.0E-4
pH 8.0	1006	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	suramin	3.0E-4
pH 8.0	1006	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1006	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1006	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1006	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1006	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1006	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1006	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1006	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1006	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1006	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1006	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1006	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1006	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1006	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1006	17391647	aclacinomycin A	0.002
	1006	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1006	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1006	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1006	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1006	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	quercetin	0.0036
pH 8.0	1006	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1006	16536579	procyanidin B2	0.0045
pH 8.0	1006	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1006	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1006	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1006	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1006	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1006	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	suramin	0.021
pH 8.0, 37°C	1006	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1006	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1006	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1006	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1006	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1006	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1006	16536579	resveratrol	0.0657
pH 8.0, 37°C	1006	17466980	coralyne	0.074
	1006	17194596	etoposide	0.0784
IC50: 0.08 mM	1006	12745084	betulinic acid	0.08
IC50: 0.081 mM	1006	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1006	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1006	17466980	quercetin	0.0889
IC50: 0.089 mM	1006	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1006	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1006	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1006	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1006	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1006	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1006	17466980	Pentamidine	1.426
pH 8.0, 37°C	1006	17466980	enoxacin	1.485
pH 8.0, 37°C	1006	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1006	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1006	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1006	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1006	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1006	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1006	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1006	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1006	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1006	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1006	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1006	18593177	VFDGEL	7.9
pH 7.9, 30°C	1006	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1007	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1007	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1007	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1007	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1007	24775914	more	-999.0
pH 8.0, 37°C	1007	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1007	16536579	myricetin	3.9E-5
at 37°C	1007	19128485	ICRF-193	2.0E-4
pH 8.0	1007	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	suramin	3.0E-4
pH 8.0	1007	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1007	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1007	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1007	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1007	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1007	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1007	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1007	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1007	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1007	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1007	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1007	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1007	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1007	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1007	17391647	aclacinomycin A	0.002
	1007	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1007	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1007	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1007	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1007	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	quercetin	0.0036
pH 8.0	1007	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1007	16536579	procyanidin B2	0.0045
pH 8.0	1007	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1007	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1007	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1007	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1007	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1007	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	suramin	0.021
pH 8.0, 37°C	1007	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1007	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1007	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1007	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1007	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1007	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1007	16536579	resveratrol	0.0657
pH 8.0, 37°C	1007	17466980	coralyne	0.074
	1007	17194596	etoposide	0.0784
IC50: 0.08 mM	1007	12745084	betulinic acid	0.08
IC50: 0.081 mM	1007	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1007	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1007	17466980	quercetin	0.0889
IC50: 0.089 mM	1007	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1007	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1007	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1007	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1007	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1007	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1007	17466980	Pentamidine	1.426
pH 8.0, 37°C	1007	17466980	enoxacin	1.485
pH 8.0, 37°C	1007	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1007	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1007	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1007	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1007	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1007	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1007	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1007	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1007	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1007	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1007	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1007	18593177	VFDGEL	7.9
pH 7.9, 30°C	1007	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1008	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1008	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1008	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1008	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1008	24775914	more	-999.0
pH 8.0, 37°C	1008	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1008	16536579	myricetin	3.9E-5
at 37°C	1008	19128485	ICRF-193	2.0E-4
pH 8.0	1008	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	suramin	3.0E-4
pH 8.0	1008	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1008	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1008	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1008	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1008	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1008	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1008	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1008	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1008	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1008	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1008	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1008	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1008	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1008	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1008	17391647	aclacinomycin A	0.002
	1008	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1008	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1008	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1008	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1008	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	quercetin	0.0036
pH 8.0	1008	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1008	16536579	procyanidin B2	0.0045
pH 8.0	1008	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1008	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1008	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1008	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1008	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1008	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	suramin	0.021
pH 8.0, 37°C	1008	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1008	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1008	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1008	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1008	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1008	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1008	16536579	resveratrol	0.0657
pH 8.0, 37°C	1008	17466980	coralyne	0.074
	1008	17194596	etoposide	0.0784
IC50: 0.08 mM	1008	12745084	betulinic acid	0.08
IC50: 0.081 mM	1008	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1008	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1008	17466980	quercetin	0.0889
IC50: 0.089 mM	1008	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1008	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1008	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1008	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1008	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1008	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1008	17466980	Pentamidine	1.426
pH 8.0, 37°C	1008	17466980	enoxacin	1.485
pH 8.0, 37°C	1008	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1008	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1008	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1008	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1008	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1008	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1008	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1008	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1008	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1008	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1008	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1008	18593177	VFDGEL	7.9
pH 7.9, 30°C	1008	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1009	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1009	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1009	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1009	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1009	24775914	more	-999.0
pH 8.0, 37°C	1009	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1009	16536579	myricetin	3.9E-5
at 37°C	1009	19128485	ICRF-193	2.0E-4
pH 8.0	1009	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	suramin	3.0E-4
pH 8.0	1009	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1009	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1009	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1009	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1009	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1009	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1009	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1009	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1009	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1009	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1009	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1009	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1009	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1009	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1009	17391647	aclacinomycin A	0.002
	1009	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1009	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1009	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1009	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1009	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	quercetin	0.0036
pH 8.0	1009	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1009	16536579	procyanidin B2	0.0045
pH 8.0	1009	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1009	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1009	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1009	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1009	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1009	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	suramin	0.021
pH 8.0, 37°C	1009	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1009	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1009	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1009	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1009	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1009	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1009	16536579	resveratrol	0.0657
pH 8.0, 37°C	1009	17466980	coralyne	0.074
	1009	17194596	etoposide	0.0784
IC50: 0.08 mM	1009	12745084	betulinic acid	0.08
IC50: 0.081 mM	1009	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1009	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1009	17466980	quercetin	0.0889
IC50: 0.089 mM	1009	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1009	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1009	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1009	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1009	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1009	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1009	17466980	Pentamidine	1.426
pH 8.0, 37°C	1009	17466980	enoxacin	1.485
pH 8.0, 37°C	1009	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1009	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1009	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1009	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1009	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1009	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1009	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1009	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1009	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1009	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1009	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1009	18593177	VFDGEL	7.9
pH 7.9, 30°C	1009	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1010	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1010	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1010	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1010	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1010	24775914	more	-999.0
pH 8.0, 37°C	1010	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1010	16536579	myricetin	3.9E-5
at 37°C	1010	19128485	ICRF-193	2.0E-4
pH 8.0	1010	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	suramin	3.0E-4
pH 8.0	1010	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1010	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1010	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1010	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1010	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1010	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1010	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1010	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1010	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1010	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1010	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1010	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1010	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1010	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1010	17391647	aclacinomycin A	0.002
	1010	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1010	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1010	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1010	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1010	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	quercetin	0.0036
pH 8.0	1010	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1010	16536579	procyanidin B2	0.0045
pH 8.0	1010	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1010	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1010	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1010	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1010	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1010	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	suramin	0.021
pH 8.0, 37°C	1010	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1010	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1010	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1010	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1010	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1010	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1010	16536579	resveratrol	0.0657
pH 8.0, 37°C	1010	17466980	coralyne	0.074
	1010	17194596	etoposide	0.0784
IC50: 0.08 mM	1010	12745084	betulinic acid	0.08
IC50: 0.081 mM	1010	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1010	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1010	17466980	quercetin	0.0889
IC50: 0.089 mM	1010	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1010	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1010	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1010	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1010	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1010	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1010	17466980	Pentamidine	1.426
pH 8.0, 37°C	1010	17466980	enoxacin	1.485
pH 8.0, 37°C	1010	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1010	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1010	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1010	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1010	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1010	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1010	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1010	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1010	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1010	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1010	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1010	18593177	VFDGEL	7.9
pH 7.9, 30°C	1010	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1011	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1011	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1011	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1011	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1011	24775914	more	-999.0
pH 8.0, 37°C	1011	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1011	16536579	myricetin	3.9E-5
at 37°C	1011	19128485	ICRF-193	2.0E-4
pH 8.0	1011	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	suramin	3.0E-4
pH 8.0	1011	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1011	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1011	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1011	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1011	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1011	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1011	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1011	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1011	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1011	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1011	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1011	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1011	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1011	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1011	17391647	aclacinomycin A	0.002
	1011	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1011	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1011	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1011	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1011	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	quercetin	0.0036
pH 8.0	1011	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1011	16536579	procyanidin B2	0.0045
pH 8.0	1011	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1011	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1011	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1011	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1011	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1011	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	suramin	0.021
pH 8.0, 37°C	1011	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1011	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1011	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1011	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1011	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1011	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1011	16536579	resveratrol	0.0657
pH 8.0, 37°C	1011	17466980	coralyne	0.074
	1011	17194596	etoposide	0.0784
IC50: 0.08 mM	1011	12745084	betulinic acid	0.08
IC50: 0.081 mM	1011	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1011	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1011	17466980	quercetin	0.0889
IC50: 0.089 mM	1011	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1011	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1011	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1011	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1011	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1011	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1011	17466980	Pentamidine	1.426
pH 8.0, 37°C	1011	17466980	enoxacin	1.485
pH 8.0, 37°C	1011	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1011	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1011	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1011	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1011	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1011	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1011	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1011	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1011	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1011	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1011	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1011	18593177	VFDGEL	7.9
pH 7.9, 30°C	1011	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1012	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1012	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1012	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1012	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1012	24775914	more	-999.0
pH 8.0, 37°C	1012	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1012	16536579	myricetin	3.9E-5
at 37°C	1012	19128485	ICRF-193	2.0E-4
pH 8.0	1012	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	suramin	3.0E-4
pH 8.0	1012	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1012	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1012	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1012	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1012	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1012	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1012	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1012	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1012	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1012	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1012	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1012	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1012	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1012	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1012	17391647	aclacinomycin A	0.002
	1012	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1012	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1012	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1012	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1012	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	quercetin	0.0036
pH 8.0	1012	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1012	16536579	procyanidin B2	0.0045
pH 8.0	1012	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1012	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1012	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1012	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1012	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1012	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	suramin	0.021
pH 8.0, 37°C	1012	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1012	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1012	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1012	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1012	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1012	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1012	16536579	resveratrol	0.0657
pH 8.0, 37°C	1012	17466980	coralyne	0.074
	1012	17194596	etoposide	0.0784
IC50: 0.08 mM	1012	12745084	betulinic acid	0.08
IC50: 0.081 mM	1012	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1012	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1012	17466980	quercetin	0.0889
IC50: 0.089 mM	1012	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1012	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1012	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1012	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1012	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1012	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1012	17466980	Pentamidine	1.426
pH 8.0, 37°C	1012	17466980	enoxacin	1.485
pH 8.0, 37°C	1012	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1012	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1012	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1012	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1012	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1012	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1012	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1012	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1012	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1012	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1012	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1012	18593177	VFDGEL	7.9
pH 7.9, 30°C	1012	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1013	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1013	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1013	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1013	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1013	24775914	more	-999.0
pH 8.0, 37°C	1013	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1013	16536579	myricetin	3.9E-5
at 37°C	1013	19128485	ICRF-193	2.0E-4
pH 8.0	1013	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	suramin	3.0E-4
pH 8.0	1013	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1013	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1013	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1013	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1013	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1013	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1013	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1013	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1013	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1013	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1013	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1013	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1013	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1013	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1013	17391647	aclacinomycin A	0.002
	1013	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1013	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1013	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1013	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1013	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	quercetin	0.0036
pH 8.0	1013	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1013	16536579	procyanidin B2	0.0045
pH 8.0	1013	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1013	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1013	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1013	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1013	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1013	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	suramin	0.021
pH 8.0, 37°C	1013	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1013	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1013	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1013	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1013	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1013	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1013	16536579	resveratrol	0.0657
pH 8.0, 37°C	1013	17466980	coralyne	0.074
	1013	17194596	etoposide	0.0784
IC50: 0.08 mM	1013	12745084	betulinic acid	0.08
IC50: 0.081 mM	1013	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1013	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1013	17466980	quercetin	0.0889
IC50: 0.089 mM	1013	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1013	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1013	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1013	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1013	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1013	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1013	17466980	Pentamidine	1.426
pH 8.0, 37°C	1013	17466980	enoxacin	1.485
pH 8.0, 37°C	1013	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1013	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1013	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1013	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1013	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1013	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1013	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1013	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1013	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1013	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1013	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1013	18593177	VFDGEL	7.9
pH 7.9, 30°C	1013	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1014	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1014	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1014	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1014	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1014	24775914	more	-999.0
pH 8.0, 37°C	1014	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1014	16536579	myricetin	3.9E-5
at 37°C	1014	19128485	ICRF-193	2.0E-4
pH 8.0	1014	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	suramin	3.0E-4
pH 8.0	1014	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1014	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1014	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1014	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1014	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1014	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1014	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1014	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1014	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1014	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1014	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1014	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1014	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1014	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1014	17391647	aclacinomycin A	0.002
	1014	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1014	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1014	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1014	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1014	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	quercetin	0.0036
pH 8.0	1014	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1014	16536579	procyanidin B2	0.0045
pH 8.0	1014	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1014	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1014	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1014	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1014	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1014	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	suramin	0.021
pH 8.0, 37°C	1014	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1014	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1014	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1014	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1014	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1014	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1014	16536579	resveratrol	0.0657
pH 8.0, 37°C	1014	17466980	coralyne	0.074
	1014	17194596	etoposide	0.0784
IC50: 0.08 mM	1014	12745084	betulinic acid	0.08
IC50: 0.081 mM	1014	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1014	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1014	17466980	quercetin	0.0889
IC50: 0.089 mM	1014	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1014	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1014	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1014	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1014	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1014	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1014	17466980	Pentamidine	1.426
pH 8.0, 37°C	1014	17466980	enoxacin	1.485
pH 8.0, 37°C	1014	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1014	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1014	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1014	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1014	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1014	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1014	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1014	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1014	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1014	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1014	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1014	18593177	VFDGEL	7.9
pH 7.9, 30°C	1014	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1015	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1015	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1015	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1015	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1015	24775914	more	-999.0
pH 8.0, 37°C	1015	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1015	16536579	myricetin	3.9E-5
at 37°C	1015	19128485	ICRF-193	2.0E-4
pH 8.0	1015	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	suramin	3.0E-4
pH 8.0	1015	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1015	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1015	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1015	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1015	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1015	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1015	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1015	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1015	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1015	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1015	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1015	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1015	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1015	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1015	17391647	aclacinomycin A	0.002
	1015	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1015	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1015	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1015	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1015	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	quercetin	0.0036
pH 8.0	1015	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1015	16536579	procyanidin B2	0.0045
pH 8.0	1015	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1015	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1015	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1015	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1015	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1015	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	suramin	0.021
pH 8.0, 37°C	1015	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1015	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1015	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1015	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1015	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1015	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1015	16536579	resveratrol	0.0657
pH 8.0, 37°C	1015	17466980	coralyne	0.074
	1015	17194596	etoposide	0.0784
IC50: 0.08 mM	1015	12745084	betulinic acid	0.08
IC50: 0.081 mM	1015	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1015	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1015	17466980	quercetin	0.0889
IC50: 0.089 mM	1015	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1015	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1015	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1015	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1015	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1015	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1015	17466980	Pentamidine	1.426
pH 8.0, 37°C	1015	17466980	enoxacin	1.485
pH 8.0, 37°C	1015	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1015	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1015	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1015	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1015	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1015	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1015	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1015	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1015	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1015	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1015	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1015	18593177	VFDGEL	7.9
pH 7.9, 30°C	1015	16819200	daunorubicin	8.5
inhibitor IC50 values in vivo in different cancer cell lines, overview	1016	19836231	more	-999.0
2-thienyl-4-furyl-6-aryl pyridine derivatives, IC50 values in cytotoxicity assays in cancer cell lines, overview	1016	19939682	more	-999.0
in vivo IC50 values of inhibitors in different cancer cell lines in a cytotoxicity assay, overview	1016	20170164	more	-999.0
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values	1016	20094661	more	-999.0
cytotoxic activity of inhibitory compounds, docking study, overview	1016	24775914	more	-999.0
pH 8.0, 37°C	1016	16536579	Epicatechin gallate	2.9E-5
pH 8.0, 37°C	1016	16536579	myricetin	3.9E-5
at 37°C	1016	19128485	ICRF-193	2.0E-4
pH 8.0	1016	17391647	N,N,N',N'-tetrakis[(7-bromo-9-chloroacridin-4-yl)methyl]butane-1,4-diamine	2.0E-4
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	suramin	3.0E-4
pH 8.0	1016	17391647	N-(acridin-1-ylmethyl)-N,N',N'-tris(acridin-2-ylmethyl)octane-1,8-diamine	4.0E-4
inhibition of DNA catenation, pH 8.0, 39°C	1016	22163192	neoamphimedine	5.0E-4
pH and temperature not specified in the publication	1016	24516330	1,3,5-trihydroxy-4-methoxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1016	24516330	1,7-dihydroxy-9H-xanthen-9-one	5.8E-4
pH and temperature not specified in the publication	1016	24516330	6,11-dihydroxy-3,3-dimethyl-5-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one	6.0E-4
	1016	17194596	8-(2-(diethylamino)ethoxy)benzofuro[3,2-g]quinoline-5,11-dione	6.8E-4
pH and temperature not specified in the publication	1016	24516330	1,5-dihydroxy-3-methoxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one	6.9E-4
pH and temperature not specified in the publication, predicted value	1016	24516330	5,8-dihydroxy-4-methoxy-3,6-bis(3-methylbut-2-en-1-yl)-4a,9a-dihydro-1H-xanthene-1,2,9-trione	7.1E-4
pH and temperature not specified in the publication, predicted value	1016	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(propan-2-yl)-9H-xanthen-9-one	7.5E-4
pH and temperature not specified in the publication, predicted value	1016	24516330	5-methoxy-1,3-bis[(2-methyloxiran-2-yl)methoxy]-7-(oxiran-2-ylmethyl)-9H-xanthen-9-one	7.9E-4
pH and temperature not specified in the publication, predicted value	1016	24516330	(2S)-2-(2-hydroxypropan-2-yl)-2,5-dimethyl-8,10-bis[(2-methyloxiran-2-yl)methoxy]-1,2-dihydro-11H-furo[3,2-a]xanthen-11-one	8.3E-4
pH 8.0	1016	17391647	N,N,N',N'-tetrakis[(9-aminoacridin-4-yl)methyl]ethane-1,2-diamine	9.0E-4
	1016	17194596	3-[2-(dimethylamino)propoxy]benzo[b]naphtho[2,3-d]furan-6,11-dione	0.00119
	1016	19560355	N2-(1,3-benzothiazol-6-yl)-N6-tert-butyl-9H-purine-2,6-diamine	0.0017
	1016	17391647	aclacinomycin A	0.002
	1016	17391647	Mitoxantrone	0.002
inhibition of ATPase activity, pH 8.0, 39°C	1016	22163192	neoamphimedine	0.002
irreversible inhibition, IC50 is 0.0025 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1016	15680922	conjugated eicosapentaenoic acid	0.0025
IC50 is 0.0027 mM	1016	15562618	sodium stibogluconate	0.0027
IC50 is 0.0028 mM	1016	15562618	sodium antimonyl(III) gluconate	0.0028
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	quercetin	0.0036
pH 8.0	1016	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)butane-1,4-diamine	0.0043
pH 8.0, 37°C	1016	16536579	procyanidin B2	0.0045
pH 8.0	1016	17391647	N,N,N',N'-tetrakis(acridin-4-ylmethyl)ethane-1,2-diamine	0.0057
pH 8.0	1016	17391647	bis(acridin-4-ylmethyl)cyanamide	0.0065
	1016	19560355	N2-(1,3-benzothiazol-6-yl)-N6-cyclohexyl-9H-purine-2,6-diamine	0.0084
irreversible inhibition, IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA, effects on thermal transition of dsDNA, overview	1016	15680922	(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid	0.01
IC50 is 0.01 mM for inhibition of decatenation of kinetoplast DNA	1016	15680922	conjugated docosahexanoic acid	0.01
IC50: 0.015 mM, the lithocholic interaction interface has a pocket comprised of three amino acids, Lys720, Leu760 and Thr791	1016	11686928	lithocholic acid	0.015
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	2-iso-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0194
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	etoposide	0.021
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	suramin	0.021
pH 8.0, 37°C	1016	17466980	ellagic acid	0.0263
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	quercetin	0.0277
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1-(4-methoxybenzyl)-1H-[1,2,3]triazolo[4,5-g]-phthalazine-4,9-dione	0.0286
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1-iso-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0298
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1-iso-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0333
IC50: 0.036 mM	1016	12745084	ursolic acid	0.036
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1-methyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.039
IC50: 0.043 mM	1016	12745084	corosolic acid	0.043
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1-n-butyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0432
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	2-n-propyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0444
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1-n-propyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.049
IC50: 0.049 mM	1016	12745084	3beta-corosolic acid	0.049
IC50 is 0.05 mM for inhibition of decatenation of kinetoplast DNA	1016	15680922	(4Z,7Z,10Z,13Z,16Z,19Z)-henicosa-4,7,10,13,16,19-hexaenoic acid	0.05
IC50: 0.05 mM	1016	11582546	etoposide	0.05
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1H-[1,2,3]triazolo[4,5,-g]phthalazine-4,9-dione	0.0528
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	2-iso-propyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0545
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	1-ethyl-1H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	2-methyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0556
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	etoposide	0.0589
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	2-ethyl-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione	0.0615
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	2-n-butyl-2H-[1,2,3] triazolo[4,5-g]phthalazine-4,9-dione	0.0648
pH 8.0, 37°C	1016	16536579	resveratrol	0.0657
pH 8.0, 37°C	1016	17466980	coralyne	0.074
	1016	17194596	etoposide	0.0784
IC50: 0.08 mM	1016	12745084	betulinic acid	0.08
IC50: 0.081 mM	1016	12745084	oleanolic acid	0.081
IC50: 0.083 mM	1016	12745084	3alpha-corosolic acid	0.083
pH 8.0, 37°C	1016	17466980	quercetin	0.0889
IC50: 0.089 mM	1016	12745084	3alpha-corosolic acid	0.089
IC50: 0.092 mM	1016	12745084	maslinic acid	0.092
in 50 mM Tris-HCl, pH 8, 120 mM KCl, 10 mM MgCl2, 0.5 mM ATP, 0.5 mM dithiothreitol, 0.03 mg/ml bovine serum albumin, at 37°C	1016	18321715	etoposide	0.0929
inhibition of DNA relaxation activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	Ciprofloxacin	0.1695
IC50: 0.186 mM	1016	11582546	3-oxolanost-9(11)-ene-24S,25-diol	0.186
inhibition of ATPase activity, pH 8.0, temperature not specified in the publication, recombinant topo2alpha	1016	20709174	Ciprofloxacin	0.797
pH 7.9, 30°C	1016	16819200	hemsleyanol	1.0
pH 8.0, 37°C	1016	17466980	Pentamidine	1.426
pH 8.0, 37°C	1016	17466980	enoxacin	1.485
pH 8.0, 37°C	1016	17466980	Ciprofloxacin	1.999
in 50 mM Tris-HCl (pH 8.0)	1016	18593177	FEITPEKNPQ	2.4
pH 7.9, 30°C	1016	16819200	(3R,4R,4aS,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	3.0
pH 7.9, 30°C	1016	16819200	(1R,1'R,6S,6'S,7S,7'S,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	4.0
pH 7.9, 30°C	1016	16819200	alpha-viniferin-13-O-beta-glucopyranoside	4.0
in 50 mM Tris-HCl (pH 8.0)	1016	18593177	IETWNPNNKP	4.0
pH 7.9, 30°C	1016	16819200	(2R,2'S,3'S)-3'-(3,5-dihydroxyphenyl)-2,2'-bis(4-hydroxyphenyl)-4-[(E)-2-(4-hydroxyphenyl)ethenyl]-2,2',3,3'-tetrahydro-3,4'-bi-1-benzofuran-6,6'-diol	5.0
pH 7.9, 30°C	1016	16819200	(4bR,5R,9S,10S,11R,12R)-10-(3,5-dihydroxyphenyl)-5,9,12-tris(4-hydroxyphenyl)-4b,5,9,10,11,12-hexahydrobenzo[6,7]cyclohepta[1,2,3-cd]furo[3,2-f][1]benzofuran-1,3,11-triol	5.0
pH 7.9, 30°C	1016	16819200	(1R,1'R,6S,6'S,7R,7'R,11bR,11b'R)-1,1',7,7'-tetrakis(4-hydroxyphenyl)-1,1',6,6',7,7',11b,11b'-octahydro-6,6'-bi-2-oxadibenzo[cd,h]azulene-4,4',8,8',10,10'-hexol	6.0
pH 7.9, 30°C	1016	16819200	(3S,4S,4aR,5S,9bS,10S)-4-(3,5-dihydroxyphenyl)-3,5,10-tris(4-hydroxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1,2,3,4-jkl]-as-indacene-2,6,8-triol	6.0
pH 7.9, 30°C	1016	16819200	(2R,3S)-2-(3,5-dihydroxyphenyl)-1-[(S)-hydroxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1H-indene-4,6-diol	7.0
in 50 mM Tris-HCl (pH 8.0)	1016	18593177	VFDGEL	7.9
pH 7.9, 30°C	1016	16819200	daunorubicin	8.5
pH 8.0, 37°C	1160	17466980	quercetin	6.0E-4
pH 8.0, 37°C	1160	17466980	enoxacin	0.0026
pH 8.0, 37°C	1160	17466980	coralyne	0.0329
pH 8.0, 37°C	1160	17466980	Ciprofloxacin	0.05
pH 8.0, 37°C	1160	17466980	Pentamidine	0.0811
pH 8.0, 37°C	1160	17466980	ellagic acid	0.413
pH 8.0, 37°C	1161	17466980	quercetin	6.0E-4
pH 8.0, 37°C	1161	17466980	enoxacin	0.0026
pH 8.0, 37°C	1161	17466980	coralyne	0.0329
pH 8.0, 37°C	1161	17466980	Ciprofloxacin	0.05
pH 8.0, 37°C	1161	17466980	Pentamidine	0.0811
pH 8.0, 37°C	1161	17466980	ellagic acid	0.413
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1322	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1322	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1322	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1322	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1322	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1322	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1322	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1322	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1322	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1322	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1323	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1323	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1323	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1323	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1323	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1323	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1323	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1323	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1323	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1323	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1324	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1324	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1324	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1324	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1324	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1324	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1324	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1324	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1324	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1324	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1325	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1325	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1325	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1325	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1325	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1325	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1325	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1325	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1325	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1325	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1326	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1326	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1326	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1326	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1326	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1326	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1326	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1326	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1326	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1326	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1327	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1327	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1327	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1327	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1327	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1327	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1327	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1327	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1327	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1327	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1328	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1328	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1328	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1328	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1328	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1328	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1328	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1328	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1328	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1328	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1329	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1329	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1329	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1329	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1329	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1329	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1329	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1329	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1329	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1329	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1330	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1330	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1330	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1330	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1330	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1330	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1330	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1330	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1330	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1330	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1331	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1331	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1331	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1331	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1331	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1331	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1331	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1331	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1331	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1331	19238256	etoposide	5.85E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1332	19238256	doxorubicin	1.83E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1332	19238256	morpholine	2.44E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1332	19238256	morpholine	2.6E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1332	19238256	doxorubicin	3.14E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1332	19238256	hexamethyleneimin	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1332	19238256	hexamethyleneimine	9.08E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1332	19238256	hexamethyleneimin	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1332	19238256	hexamethyleneimine	9.4E-5
pH 7.5, 37°C, cytotoxicity assay in L1210 cells	1332	19238256	etoposide	3.29E-4
pH 7.5, 37°C, cytotoxicity assay in L1210 cells in presence of inhibitor ICRF-187	1332	19238256	etoposide	5.85E-4
0.001 mM inhibits 40%, 0.005 mM inhibits 90%, IC50: 0.003 mM, inhibits by trapping enzyme-DNA cleavage complexes, which in turn produces anticancer effects	1725	11551518	salvicine	0.003
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.05 mM, inhibition mechanism via complex formation, overview	1725	15907782	thiomorpholide amido methyl ferrocene	0.05
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.1 mM, inhibition mechanism via complex formation, overview	1725	15907782	azalactone ferrocene	0.1
0.001 mM inhibits 40%, 0.005 mM inhibits 90%, IC50: 0.003 mM, inhibits by trapping enzyme-DNA cleavage complexes, which in turn produces anticancer effects	1726	11551518	salvicine	0.003
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.05 mM, inhibition mechanism via complex formation, overview	1726	15907782	thiomorpholide amido methyl ferrocene	0.05
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.1 mM, inhibition mechanism via complex formation, overview	1726	15907782	azalactone ferrocene	0.1
0.001 mM inhibits 40%, 0.005 mM inhibits 90%, IC50: 0.003 mM, inhibits by trapping enzyme-DNA cleavage complexes, which in turn produces anticancer effects	1727	11551518	salvicine	0.003
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.05 mM, inhibition mechanism via complex formation, overview	1727	15907782	thiomorpholide amido methyl ferrocene	0.05
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.1 mM, inhibition mechanism via complex formation, overview	1727	15907782	azalactone ferrocene	0.1
0.001 mM inhibits 40%, 0.005 mM inhibits 90%, IC50: 0.003 mM, inhibits by trapping enzyme-DNA cleavage complexes, which in turn produces anticancer effects	1728	11551518	salvicine	0.003
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.05 mM, inhibition mechanism via complex formation, overview	1728	15907782	thiomorpholide amido methyl ferrocene	0.05
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.1 mM, inhibition mechanism via complex formation, overview	1728	15907782	azalactone ferrocene	0.1
0.001 mM inhibits 40%, 0.005 mM inhibits 90%, IC50: 0.003 mM, inhibits by trapping enzyme-DNA cleavage complexes, which in turn produces anticancer effects	1729	11551518	salvicine	0.003
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.05 mM, inhibition mechanism via complex formation, overview	1729	15907782	thiomorpholide amido methyl ferrocene	0.05
specific inhibition of DNA passage and ATPase activities of isozyme IIbeta with IC50 of 0.1 mM, inhibition mechanism via complex formation, overview	1729	15907782	azalactone ferrocene	0.1
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1916	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1916	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1917	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1917	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1918	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1918	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1919	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1919	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1920	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1920	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1921	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1921	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1922	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1922	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1923	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1923	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1924	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1924	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1925	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1925	20686482	Ciprofloxacin	0.031
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1926	20686482	6-methoxy-4-(2-[4-[([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino]piperidin-1-yl]ethyl)quinoline-3-carbonitrile	1.4E-5
pH not specified in the publication, temperature not specified in the publication; pH not specified in the publication, temperature not specified in the publication	1926	20686482	Ciprofloxacin	0.031
